Lista de obras - J. Briones - Dominio Público Uruguay

A short CD3/CD28 costimulation combined with IL-21 enhance the generation of human memory stem T cells for adoptive immunotherapy.

artículo científico publicado en 2016

Activation of the NF-kappaB signalling pathway in diffuse large B-cell lymphoma: clinical implications

scientific article published on 01 October 2008

Activation-associated phenotype of CD3 T cells in acute graft-versus-host disease

scientific article published on 01 July 2006

Allogeneic hematopoietic stem cell transplantation for non-Hodgkin's lymphomas: a retrospective analysis of 77 cases.

artículo científico publicado en 2017

Allogenic transplants with peripheral blood progenitor cells: a report of six cases

artículo científico publicado en 1996

Antitumor immunity after vaccination with B lymphoma cells overexpressing a triad of costimulatory molecules.

artículo científico publicado en 2003

Assessment of Confirmed Clinical Hypersensitivity to Rituximab in Patients Affected with B-Cell Neoplasia

artículo científico publicado en 2020

Autologous stem cell transplantation after conditioning with yttrium-90 ibritumomab tiuxetan BEAM in refractory non-Hodgkin diffuse large B-cell lymphoma: results of a prospective, multicenter, phase II clinical trial

artículo científico publicado en 2014

Autologous stem cell transplantation after conditioning with yttrium-90 ibritumomab tiuxetan plus BEAM in refractory non-Hodgkin diffuse large B-cell lymphoma: results of a prospective, multicenter, phase II clinical trial.

scientific article published on 25 October 2013

Autologous stem cell transplantation in advanced follicular lymphoma. A single center experience

artículo científico publicado en 1999

BLyS and BLyS receptor expression in non-Hodgkin's lymphoma

artículo científico publicado en 2002

Bcl-10 protein highly correlates with the expression of phosphorylated p65 NF-kappaB in peripheral T-cell lymphomas and is associated with clinical outcome.

artículo científico publicado en 2009

Bendamustine as part of conditioning of autologous stem cell transplantation in patients with aggressive lymphoma: a phase 2 study from the GELTAMO group

artículo científico publicado en 2018

CD34+-enriched–CD19+-depleted autologous peripheral blood stem cell transplantation for chronic lymphoproliferative disorders

artículo científico publicado en 2002

Clinical utility of bone marrow flow cytometry in B-cell non-Hodgkin lymphomas (B-NHL)

scientific article published on 01 September 2004

Comparison of two pretransplant predictive models and a flexible HCT-CI using different cut off points to determine low-, intermediate-, and high-risk groups: the flexible HCT-CI Is the best predictor of NRM and OS in a population of patients underg

artículo científico publicado en 2009

Conventional versus reduced-intensity conditioning regimen for allogeneic stem cell transplantation in patients with hematological malignancies

artículo científico publicado en 2005

Degree of mucositis and duration of neutropenia are the major risk factors for early post-transplant febrile neutropenia and severe bacterial infections after reduced-intensity conditioning

artículo científico publicado en 2012

Demonstration of donor origin of CD34+ HLA-DR- bone marrow cells after allogeneic peripheral blood transplantation with a long follow-up

scientific article published on 01 January 1998

Dendritic and tumor cell fusions transduced with adenovirus encoding CD40L eradicate B-cell lymphoma and induce a Th17-type response.

artículo científico publicado en 2009

Dendritic cells combined with tumor cells and α-galactosylceramide induce a potent, therapeutic and NK-cell dependent antitumor immunity in B cell lymphoma.

artículo científico publicado en 2017

Do Patients and Physicians Agree When They Assess Quality of Life?

artículo científico publicado en 2017

Does reduced-intensity allogeneic transplantation confer a survival advantage to patients with poor prognosis chronic lymphocytic leukaemia? A case-control retrospective analysis

artículo científico publicado en 2009

Early and late neurological complications after reduced-intensity conditioning allogeneic stem cell transplantation.

artículo científico publicado en 2009

Early clinical impact of iron overload in stem cell transplantation. A prospective study.

artículo científico publicado en 2007

Effects of G-CSF administration and peripheral blood progenitor cell collection in 20 healthy donors.

artículo científico publicado en 1996

Efficient transduction of human hematopoietic repopulating cells generating stable engraftment of transgene-expressing cells in NOD/SCID mice.

artículo científico publicado en 2000

Emerging therapies for patients with advanced chronic lymphocytic leukaemia.

scientific article published on 29 July 2009

Encouraging results with inolimomab (anti-IL-2 receptor) as treatment for refractory acute graft-versus-host disease

artículo científico publicado en 2006

Epidemiology of lymphoid malignancies: last decade update.

artículo científico publicado en 2013

Fludarabine-induced apoptosis in CD19+/CD5+B-CLL cells is a direct and nurse-like-cell independent effect.

artículo científico publicado en 2004

Focal adhesion protein expression in human diffuse large B-cell lymphoma

artículo científico publicado en 2014

Frequent severe liver iron overload after stem cell transplantation and its possible association with invasive aspergillosis

scientific article published on 01 September 2004

Heat-shock proteins: a c-Myc lymphoma target?

artículo científico publicado en 2015

High clinical and molecular response rates with fludarabine, cyclophosphamide and mitoxantrone in previously untreated patients with advanced stage follicular lymphoma.

artículo científico publicado en 2008

High frequency of donor chimerism after allogeneic transplantation of CD34+-selected peripheral blood cells

scientific article published on 01 May 1998

High-titer retroviral vectors containing the enhanced green fluorescent protein gene for efficient expression in hematopoietic cells.

artículo científico publicado en 1997

Hodgkin's disease presenting as a cholestatic febrile illness: incidence and main characteristics in a series of 421 patients.

artículo científico publicado en 1996

Hypercalcemia in a patient with chronic lymphocytic leukemia evolving into Richter's syndrome

scientific article published on 01 May 1996

Identification of leptomeningeal disease in aggressive B-cell non-Hodgkin's lymphoma: improved sensitivity of flow cytometry.

artículo científico publicado en 2009

Impact of Epstein Barr virus-related complications after high-risk allo-SCT in the era of pre-emptive rituximab.

artículo científico publicado en 2015

Impact of cyclosporine levels on the development of acute graft versus host disease after reduced intensity conditioning allogeneic stem cell transplantation.

scientific article published on 30 January 2014

In vivo antitumor effect of CD40L-transduced tumor cells as a vaccine for B-cell lymphoma

artículo científico publicado en 2002

Insertion of the CCND1 gene into the IgH locus in a case of leukaemic small cell mantle lymphoma with normal chromosomes 11 and 14.

artículo científico publicado en 2003

Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets.

artículo científico publicado en 2017

Intensive chemotherapy (high-dose CHOP/ESHAP regimen) followed by autologous stem-cell transplantation in previously untreated patients with peripheral T-cell lymphoma

artículo científico publicado en 2008

Interleukin-15 enhances rituximab-dependent cytotoxicity against chronic lymphocytic leukemia cells and overcomes transforming growth factor beta-mediated immunosuppression

artículo científico publicado en 2011

International and Italian prognostic indices in follicular lymphoma.

artículo científico publicado en 2003

Iron overload might increase transplant-related mortality in haematopoietic stem cell transplantation

artículo científico publicado en 2002

LITAF, a BCL6 target gene, regulates autophagy in mature B-cell lymphomas.

artículo científico publicado en 2013

Long-Term Follow-Up of a Phase II Trial of Six Cycles of Dose-Dense R-CHOP-14 for First-Line Treatment of Diffuse Large B-Cell Lymphoma in Young and Elderly Patients.

artículo científico publicado en 2016

Long-term safety and outcome of fludarabine, cyclophosphamide and mitoxantrone (FCM) regimen in previously untreated patients with advanced follicular lymphoma: 12 years follow-up of a phase 2 trial

artículo científico publicado en 2017

Low transplant related mortality in older patients with hematologic malignancies undergoing autologous stem cell transplantation

scientific article published on 01 March 2003

Lower respiratory tract respiratory virus infections increase the risk of invasive aspergillosis after a reduced-intensity allogeneic hematopoietic SCT.

artículo científico publicado en 2009

MYC protein expression and genetic alterations have prognostic impact in patients with diffuse large B-cell lymphoma treated with immunochemotherapy.

scientific article published on 28 May 2013

Membrane PKC-beta 2 protein expression predicts for poor response to chemotherapy and survival in patients with diffuse large B-cell lymphoma

artículo científico publicado en 2006

MicroRNAs are independent predictors of outcome in diffuse large B-cell lymphoma patients treated with R-CHOP.

artículo científico publicado en 2011

Mobilization kinetics of peripheral blood progenitor cells after IAPVP-16 salvage chemotherapy plus G-CSF in lymphoproliferative disorders

scientific article published on 01 July 2000

Multicenter phase II study of plitidepsin in patients with relapsed/refractory non-Hodgkin's lymphoma.

artículo científico publicado en 2012

Myeloablative versus reduced intensity allogeneic stem cell transplantation for relapsed/refractory Hodgkin's lymphoma in recent years: a retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

artículo científico publicado en 2016

NK cells stimulated with IL-15 or CpG ODN enhance rituximab-dependent cellular cytotoxicity against B-cell lymphoma.

artículo científico publicado en 2007

New therapies in non-Hodgkin lymphoma

artículo científico

PET/CT Assessment of Follicular Lymphoma and High Grade B Cell Lymphoma - Good Correlation with Clinical and Histological Features at Diagnosis.

artículo científico publicado en 2015

Paraffin-based 6-gene model predicts outcome in diffuse large B-cell lymphoma patients treated with R-CHOP.

artículo científico publicado en 2008

Patients with biochemical iron overload: causes and characteristics of a cohort of 150 cases

scientific article published on 07 February 2003

Patterns of infection and infection-related mortality in patients with steroid-refractory acute graft versus host disease.

artículo científico publicado en 2016

Phase II Study of Yttrium-90-Ibritumomab Tiuxetan as Part of Reduced-Intensity Conditioning (with Melphalan, Fludarabine ± Thiotepa) for Allogeneic Transplantation in Relapsed or Refractory Aggressive B Cell Lymphoma: A GELTAMO Trial

artículo científico

Phase II trial of ofatumumab plus ESHAP (O-ESHAP) as salvage treatment for patients with relapsed or refractory classical Hodgkin lymphoma after first-line chemotherapy.

artículo científico publicado en 2016

Preference for Rituximab Subcutaneous (Sc) and Intravenous (Iv) Among Patients With Cd20+ Non-Hodgkin's Lymphoma (Nhl) Completing the Rasq Measure In Randomized Phase Iii Studies Prefmab and Mabcute

artículo científico publicado en 2014

Prognostic indexes in follicular lymphoma: a comparison of different prognostic systems.

artículo científico publicado en 2005

Prospective phase II trial of extended treatment with rituximab in patients with B-cell post-transplant lymphoproliferative disease

artículo científico publicado en 2007

Pulmonary function testing prior to reduced intensity conditioning allogeneic stem cell transplantation in an unselected patient cohort predicts posttransplantation pulmonary complications and outcome

artículo científico publicado en 2011

Rapid engraftment without significant graft-versus-host disease after allogeneic transplantation of CD34+ selected cells from peripheral blood

scientific article published on 01 June 1997

Reduced-intensity conditioning allogeneic blood stem cell transplantation with fludarabine and oral busulfan with or without pharmacokinetically targeted busulfan dosing in patients with myeloid leukemia ineligible for conventional conditioning.

artículo científico publicado en 2005

Reduced-intensity conditioning allogeneic hematopoietic cell transplantation using oral fludarabine as part of the conditioning regimen.

artículo científico publicado en 2009

Reduction of infection-related mortality after allogeneic PBSCT from HLA-identical siblings: longitudinal analysis from 1994 to 2008 at a single institution

artículo científico publicado en 2010

Role of the STAT1 pathway in apoptosis induced by fludarabine and JAK kinase inhibitors in B-cell chronic lymphocytic leukemia.

artículo científico publicado en 2005

Strategies to reduce transplant-related mortality after allogeneic stem cell transplantation in elderly patients: Comparison of reduced-intensity conditioning and unmanipulated peripheral blood stem cells vs a myeloablative regimen and CD34+ cell se ⬇️

artículo científico publicado el 1 de noviembre de 2003

Study of hematopoietic chimerism following allogeneic peripheral blood stem cell transplantation using PCR amplification of short tandem repeats

artículo científico publicado en 1996

Study of kidney function impairment after reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation. A single-center experience.

artículo científico publicado en 2009

T-cell costimulatory molecules in acute-graft-versus host disease: therapeutic implications.

artículo científico publicado en 2010

Targeted therapy of BCL6-dependent diffuse large B-cell lymphomas by heat-shock protein 90 inhibition

artículo científico publicado en 2010

Therapeutic vaccines for non-Hodgkin B-cell lymphoma.

artículo científico publicado en 2008

Total body-surface area as a new prognostic variable in mycosis fungoides and Sézary syndrome

artículo científico publicado en 2016

Transfusion-associated graft-versus-host disease (TA-GVHD) in fludarabine-treated patients: is it time to irradiate blood component?

artículo científico publicado en 1996

Using the Lymph2Cx assay for assessing cell-of-origin subtypes of HIV-related diffuse large B-cell lymphoma

article

[Allogeneic transplant of peripheral blood hematopoietic progenitors. Preliminary experience]

scientific article published on 01 January 1996

[Treatment with fludarabine of lymphoid neoplasms with low grade malignity resistant to treatment or in relapse]

artículo científico publicado en 1996

Lista de obras de J. Briones

A short CD3/CD28 costimulation combined with IL-21 enhance the generation of human memory stem T cells for adoptive immunotherapy.

Activation of the NF-kappaB signalling pathway in diffuse large B-cell lymphoma: clinical implications

Activation-associated phenotype of CD3 T cells in acute graft-versus-host disease

Allogeneic hematopoietic stem cell transplantation for non-Hodgkin's lymphomas: a retrospective analysis of 77 cases.

Allogenic transplants with peripheral blood progenitor cells: a report of six cases

Antitumor immunity after vaccination with B lymphoma cells overexpressing a triad of costimulatory molecules.

Assessment of Confirmed Clinical Hypersensitivity to Rituximab in Patients Affected with B-Cell Neoplasia

Autologous stem cell transplantation after conditioning with yttrium-90 ibritumomab tiuxetan BEAM in refractory non-Hodgkin diffuse large B-cell lymphoma: results of a prospective, multicenter, phase II clinical trial

Autologous stem cell transplantation after conditioning with yttrium-90 ibritumomab tiuxetan plus BEAM in refractory non-Hodgkin diffuse large B-cell lymphoma: results of a prospective, multicenter, phase II clinical trial.

Autologous stem cell transplantation in advanced follicular lymphoma. A single center experience

BLyS and BLyS receptor expression in non-Hodgkin's lymphoma

Bcl-10 protein highly correlates with the expression of phosphorylated p65 NF-kappaB in peripheral T-cell lymphomas and is associated with clinical outcome.

Bendamustine as part of conditioning of autologous stem cell transplantation in patients with aggressive lymphoma: a phase 2 study from the GELTAMO group

CD34+-enriched–CD19+-depleted autologous peripheral blood stem cell transplantation for chronic lymphoproliferative disorders

Clinical utility of bone marrow flow cytometry in B-cell non-Hodgkin lymphomas (B-NHL)

Comparison of two pretransplant predictive models and a flexible HCT-CI using different cut off points to determine low-, intermediate-, and high-risk groups: the flexible HCT-CI Is the best predictor of NRM and OS in a population of patients underg

Conventional versus reduced-intensity conditioning regimen for allogeneic stem cell transplantation in patients with hematological malignancies

Degree of mucositis and duration of neutropenia are the major risk factors for early post-transplant febrile neutropenia and severe bacterial infections after reduced-intensity conditioning

Demonstration of donor origin of CD34+ HLA-DR- bone marrow cells after allogeneic peripheral blood transplantation with a long follow-up

Dendritic and tumor cell fusions transduced with adenovirus encoding CD40L eradicate B-cell lymphoma and induce a Th17-type response.

Dendritic cells combined with tumor cells and α-galactosylceramide induce a potent, therapeutic and NK-cell dependent antitumor immunity in B cell lymphoma.

Do Patients and Physicians Agree When They Assess Quality of Life?

Does reduced-intensity allogeneic transplantation confer a survival advantage to patients with poor prognosis chronic lymphocytic leukaemia? A case-control retrospective analysis

Early and late neurological complications after reduced-intensity conditioning allogeneic stem cell transplantation.

Early clinical impact of iron overload in stem cell transplantation. A prospective study.

Effects of G-CSF administration and peripheral blood progenitor cell collection in 20 healthy donors.

Efficient transduction of human hematopoietic repopulating cells generating stable engraftment of transgene-expressing cells in NOD/SCID mice.

Emerging therapies for patients with advanced chronic lymphocytic leukaemia.

Encouraging results with inolimomab (anti-IL-2 receptor) as treatment for refractory acute graft-versus-host disease

Epidemiology of lymphoid malignancies: last decade update.

Fludarabine-induced apoptosis in CD19+/CD5+B-CLL cells is a direct and nurse-like-cell independent effect.

Focal adhesion protein expression in human diffuse large B-cell lymphoma

Frequent severe liver iron overload after stem cell transplantation and its possible association with invasive aspergillosis

Heat-shock proteins: a c-Myc lymphoma target?

High clinical and molecular response rates with fludarabine, cyclophosphamide and mitoxantrone in previously untreated patients with advanced stage follicular lymphoma.

High frequency of donor chimerism after allogeneic transplantation of CD34+-selected peripheral blood cells

High-titer retroviral vectors containing the enhanced green fluorescent protein gene for efficient expression in hematopoietic cells.

Hodgkin's disease presenting as a cholestatic febrile illness: incidence and main characteristics in a series of 421 patients.

Hypercalcemia in a patient with chronic lymphocytic leukemia evolving into Richter's syndrome

Identification of leptomeningeal disease in aggressive B-cell non-Hodgkin's lymphoma: improved sensitivity of flow cytometry.

Impact of Epstein Barr virus-related complications after high-risk allo-SCT in the era of pre-emptive rituximab.

Impact of cyclosporine levels on the development of acute graft versus host disease after reduced intensity conditioning allogeneic stem cell transplantation.

In vivo antitumor effect of CD40L-transduced tumor cells as a vaccine for B-cell lymphoma

Insertion of the CCND1 gene into the IgH locus in a case of leukaemic small cell mantle lymphoma with normal chromosomes 11 and 14.

Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets.

Intensive chemotherapy (high-dose CHOP/ESHAP regimen) followed by autologous stem-cell transplantation in previously untreated patients with peripheral T-cell lymphoma

Interleukin-15 enhances rituximab-dependent cytotoxicity against chronic lymphocytic leukemia cells and overcomes transforming growth factor beta-mediated immunosuppression

International and Italian prognostic indices in follicular lymphoma.

Iron overload might increase transplant-related mortality in haematopoietic stem cell transplantation

LITAF, a BCL6 target gene, regulates autophagy in mature B-cell lymphomas.

Long-Term Follow-Up of a Phase II Trial of Six Cycles of Dose-Dense R-CHOP-14 for First-Line Treatment of Diffuse Large B-Cell Lymphoma in Young and Elderly Patients.

Long-term safety and outcome of fludarabine, cyclophosphamide and mitoxantrone (FCM) regimen in previously untreated patients with advanced follicular lymphoma: 12 years follow-up of a phase 2 trial

Low transplant related mortality in older patients with hematologic malignancies undergoing autologous stem cell transplantation

Lower respiratory tract respiratory virus infections increase the risk of invasive aspergillosis after a reduced-intensity allogeneic hematopoietic SCT.

MYC protein expression and genetic alterations have prognostic impact in patients with diffuse large B-cell lymphoma treated with immunochemotherapy.

Membrane PKC-beta 2 protein expression predicts for poor response to chemotherapy and survival in patients with diffuse large B-cell lymphoma

MicroRNAs are independent predictors of outcome in diffuse large B-cell lymphoma patients treated with R-CHOP.

Mobilization kinetics of peripheral blood progenitor cells after IAPVP-16 salvage chemotherapy plus G-CSF in lymphoproliferative disorders

Multicenter phase II study of plitidepsin in patients with relapsed/refractory non-Hodgkin's lymphoma.

Myeloablative versus reduced intensity allogeneic stem cell transplantation for relapsed/refractory Hodgkin's lymphoma in recent years: a retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

NK cells stimulated with IL-15 or CpG ODN enhance rituximab-dependent cellular cytotoxicity against B-cell lymphoma.

New therapies in non-Hodgkin lymphoma

PET/CT Assessment of Follicular Lymphoma and High Grade B Cell Lymphoma - Good Correlation with Clinical and Histological Features at Diagnosis.

Paraffin-based 6-gene model predicts outcome in diffuse large B-cell lymphoma patients treated with R-CHOP.

Patients with biochemical iron overload: causes and characteristics of a cohort of 150 cases

Patterns of infection and infection-related mortality in patients with steroid-refractory acute graft versus host disease.

Phase II Study of Yttrium-90-Ibritumomab Tiuxetan as Part of Reduced-Intensity Conditioning (with Melphalan, Fludarabine ± Thiotepa) for Allogeneic Transplantation in Relapsed or Refractory Aggressive B Cell Lymphoma: A GELTAMO Trial

Phase II trial of ofatumumab plus ESHAP (O-ESHAP) as salvage treatment for patients with relapsed or refractory classical Hodgkin lymphoma after first-line chemotherapy.

Preference for Rituximab Subcutaneous (Sc) and Intravenous (Iv) Among Patients With Cd20+ Non-Hodgkin's Lymphoma (Nhl) Completing the Rasq Measure In Randomized Phase Iii Studies Prefmab and Mabcute

Prognostic indexes in follicular lymphoma: a comparison of different prognostic systems.

Prospective phase II trial of extended treatment with rituximab in patients with B-cell post-transplant lymphoproliferative disease

Pulmonary function testing prior to reduced intensity conditioning allogeneic stem cell transplantation in an unselected patient cohort predicts posttransplantation pulmonary complications and outcome

Rapid engraftment without significant graft-versus-host disease after allogeneic transplantation of CD34+ selected cells from peripheral blood

Reduced-intensity conditioning allogeneic blood stem cell transplantation with fludarabine and oral busulfan with or without pharmacokinetically targeted busulfan dosing in patients with myeloid leukemia ineligible for conventional conditioning.

Reduced-intensity conditioning allogeneic hematopoietic cell transplantation using oral fludarabine as part of the conditioning regimen.

Reduction of infection-related mortality after allogeneic PBSCT from HLA-identical siblings: longitudinal analysis from 1994 to 2008 at a single institution

Role of the STAT1 pathway in apoptosis induced by fludarabine and JAK kinase inhibitors in B-cell chronic lymphocytic leukemia.

Strategies to reduce transplant-related mortality after allogeneic stem cell transplantation in elderly patients: Comparison of reduced-intensity conditioning and unmanipulated peripheral blood stem cells vs a myeloablative regimen and CD34+ cell se ⬇️

Study of hematopoietic chimerism following allogeneic peripheral blood stem cell transplantation using PCR amplification of short tandem repeats